Nizatidine EP Impurity F

Nizatidine EP Impurity F is an impurity present in nizatidine which says early clinical experience suggests that it is a useful alternative to the histamine H2-receptor antagonists presently in clinical use, after oral administration of nizatidine peak plasma concentrations is achieved within 1 to 3 hours.

Additional information

Catalogue No.

VE006309

CAS No.

N/A

Molecular Formula

C15H25N7O4S3 ;

Molecular Weight

463.60

IUPAC Name

(EZ)-N1, N1′-[Thiazole-2, 4-diylbis(methylenesulphanediylethylene)] bis(N′-methyl-2-nitroethene-1, 1-diamine)

References

“STABILITY-INDICATING LC METHOD for the ESTIMATION of NIZATIDINE IMPURITIES in NIZATIDINE ORAL SOLUTION.” Journal of Liquid Chromatography & Related Technologies, 2014, http://www.tandfonline.com/doi/abs/10.1080/10826076.2013.765461.?Price, Allan H., and Rex N. Brogden. “Nizatidine.” Drugs, vol. 36, no. 5, Nov. 1988, pp. 521–39, https://doi.org/10.2165/00003495-198836050-00002.?

Status

In-stock